Stockreport

ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Precl...

ZyVersa Therapeutics, Inc.  (ZVSA) 
PDF Cardiac complications following a stroke are a leading cause of mortality and morbidity, second only to acute neurological injury. The pathomechanism underlying cardi [Read more]